Tapewire

Nasdaq · USD

MIRA

MIRA PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
7362
SEC CIK
0001904286
Parsed reports
54

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 12, 2026 Filed Jun 15, 2026 21:00 UTC GrantStock Options (right to buy) · Derivative 50,000 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001493152-26-028715 · ownership.xml · derivative · entry 1

Whalen Matthew Pratt · CIK 0002033867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-06-12

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.

F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each.

Read SEC document
June 12, 2026 Filed Jun 15, 2026 21:00 UTC GrantStock Options (right to buy) · Derivative 50,000 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001493152-26-028714 · ownership.xml · derivative · entry 1

Shekhat Denil Nanji · CIK 0002016605 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-06-12

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.

F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each.

Read SEC document
June 12, 2026 Filed Jun 15, 2026 21:00 UTC GrantStock Options (right to buy) · Derivative 50,000 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001493152-26-028712 · ownership.xml · derivative · entry 1

Del Giudice Matthew Paul · CIK 0002016630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-06-12

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.

F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each.

Read SEC document
June 12, 2026 Filed Jun 15, 2026 21:00 UTC GrantStock Options (right to buy) · Derivative 50,000 $0.00 Strike: $0.94 $0.00
Disclosure

SEC source: 0001493152-26-028713 · ownership.xml · derivative · entry 1

MacPherson Edward Clouston · CIK 0002015989 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-06-12

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.

F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each.

Read SEC document
March 30, 2026 Filed Apr 1, 2026 21:00 UTC
Aminov ErezDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 83,500 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-014697 · ownership.xml · derivative · entry 1

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,500

Underlying: Common Stock · 83,500 shares

Expires 2036-03-30

F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of Issuer's common stock.

F2 · derivative.exercise_date: The RSUs were issued to the Reporting Person on the Grant Date, pursuant to the Plan. All of the RSU shall vested on the Grant Date.

Read SEC document
December 17, 2025 Filed Feb 18, 2026 01:30 UTC
Aminov ErezDirector · CEO and Chairman
GrantStock Options (right to buy) · Derivative 3,155,170 $0.00 Strike: $1.45 $0.00
Disclosure

SEC source: 0001493152-26-007226 · ownership.xml · derivative · entry 8

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,155,170

Underlying: Common Stock · 3,155,170 shares

Expires 2035-12-17

F1 · derivative.exercise_price: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4.

F5 · kind: Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance.

F5 · shares: Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance.

F5 · derivative.exercise_date: Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance.

F5 · derivative.underlying_shares: Represents grants of options with underlying shares of Common Stock under the Plan, for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The options hereunder vested upon issuance.

Read SEC document
October 16, 2025 Filed Feb 18, 2026 01:30 UTC
Aminov ErezDirector · CEO and Chairman
Exercise / conversionStock Options (right to buy) · Derivative 379,000 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001493152-26-007226 · ownership.xml · derivative · entry 7

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 379,000

Underlying: Common Stock · 379,000 shares

Expires 2034-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Represents exercise of 379,000 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.84 each.

Read SEC document
October 16, 2025 Filed Feb 18, 2026 01:30 UTC
Aminov ErezDirector · CEO and Chairman
Exercise / conversionStock Options (right to buy) · Derivative 234,595 $0.00 Strike: $1.16 $0.00
Disclosure

SEC source: 0001493152-26-007226 · ownership.xml · derivative · entry 6

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 234,595

Underlying: Common Stock · Not disclosed shares

Expires 2034-03-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Represents exercise of 234,595 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on March 26, 2024, with 50% of such options vesting on the six-month anniversary date of the grant, and the remaining half vesting on the one-year anniversary date of the grant, pursuant to a grant under the Plan at an exercise price of $1.16 each.

Read SEC document
October 16, 2025 Filed Feb 18, 2026 01:30 UTC
Aminov ErezDirector · CEO and Chairman
SaleCommon Stock 613,595 $2.11 $1,294,685.45
Disclosure

SEC source: 0001493152-26-007226 · ownership.xml · nonDerivative · entry 5

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,592,666

F1 · kind: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4.

Read SEC document
October 16, 2025 Filed Feb 18, 2026 01:30 UTC
Aminov ErezDirector · CEO and Chairman
Exercise / conversionCommon Stock 379,000 $0.84 $318,360.00
Disclosure

SEC source: 0001493152-26-007226 · ownership.xml · nonDerivative · entry 4

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,206,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4.

F4 · kind: Represents exercise of 379,000 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.84 each.

F4 · price: Represents exercise of 379,000 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.84 each.

Read SEC document
October 16, 2025 Filed Feb 18, 2026 01:30 UTC
Aminov ErezDirector · CEO and Chairman
Exercise / conversionCommon Stock 234,595 $1.16 $272,130.20
Disclosure

SEC source: 0001493152-26-007226 · ownership.xml · nonDerivative · entry 3

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,827,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4.

F3 · kind: Represents exercise of 234,595 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on March 26, 2024, with 50% of such options vesting on the six-month anniversary date of the grant, and the remaining half vesting on the one-year anniversary date of the grant, pursuant to a grant under the Plan at an exercise price of $1.16 each.

F3 · price: Represents exercise of 234,595 stock options to purchase Common Stock under the Plan that were issued to the Reporting Person on March 26, 2024, with 50% of such options vesting on the six-month anniversary date of the grant, and the remaining half vesting on the one-year anniversary date of the grant, pursuant to a grant under the Plan at an exercise price of $1.16 each.

Read SEC document
October 01, 2025 Filed Oct 4, 2025 00:00 UTC GrantCommon Stock 22,378 $1.35 $30,210.30
Disclosure

SEC source: 0001493152-25-016958 · ownership.xml · nonDerivative · entry 1

Shekhat Denil Nanji · CIK 0002016605 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,378

F1 · security: Represents 22,378 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc.

F1 · price: Represents 22,378 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc.

Read SEC document
October 01, 2025 Filed Oct 4, 2025 00:00 UTC
Aminov ErezDirector · Chief Executive Officer
GrantCommon Stock 2,685,456 Not disclosed Not disclosed
Disclosure

SEC source: 0001493152-25-016957 · ownership.xml · nonDerivative · entry 1

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,530,156

F1 · security: Represents 2,685,456 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc.

F1 · price: Represents 2,685,456 restricted shares of common stock, par value $0.0001 of the Issuer issued as compensation for the Issuer's acquisition of SKNY Pharmaceuticals, Inc.

Read SEC document
September 18, 2025 Filed Sep 19, 2025 00:00 UTC
Aminov ErezDirector · Chief Executive Officer
GrantStock Options (right to buy) · Derivative 150,000 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001493152-25-014114 · ownership.xml · derivative · entry 2

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-08-17

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on September 15, 2025.

F4 · kind: The board of directors of the Company approved to reprice the options from its previous exercise price of $6.50 to $1.38. All of the other terms of the option remain unchanged.

F5 · shares: The options were previously issued to the Reporting Person on August 17, 2023, and are now fully vested.

F2 · derivative.exercise_date: The board of directors of the Company approved to reprice the options from its previous exercise price of $5.00 to $1.38. All of the other terms of the option remain unchanged.

F5 · derivative.underlying_shares: The options were previously issued to the Reporting Person on August 17, 2023, and are now fully vested.

Read SEC document
September 18, 2025 Filed Sep 19, 2025 00:00 UTC
Aminov ErezDirector · Chief Executive Officer
GrantStock Options (right to buy) · Derivative 150,000 $0.00 Strike: $1.38 $0.00
Disclosure

SEC source: 0001493152-25-014114 · ownership.xml · derivative · entry 1

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-04-28

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on September 15, 2025.

F2 · kind: The board of directors of the Company approved to reprice the options from its previous exercise price of $5.00 to $1.38. All of the other terms of the option remain unchanged.

F3 · shares: The options were previously issued to the Reporting Person on April 28, 2023, and are now fully vested.

F2 · derivative.exercise_date: The board of directors of the Company approved to reprice the options from its previous exercise price of $5.00 to $1.38. All of the other terms of the option remain unchanged.

F3 · derivative.underlying_shares: The options were previously issued to the Reporting Person on April 28, 2023, and are now fully vested.

Read SEC document
August 29, 2025 Filed Sep 3, 2025 20:05 UTC
Aminov ErezDirector · Chief Executive Officer
GrantCommon Stock 62,500 $1.37 $85,625.00
Disclosure

SEC source: 0001641172-25-026388 · ownership.xml · nonDerivative · entry 1

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 844,700

F1 · security: Represents 62,500 RSUs vesting immediately, granted and issued to the Reporting Person from the Issuer's 2022 Omnibus Incentive Plan in connection with the Reporting Person's achievement of certain milestones pursuant to the Reporting Person's Executive Incentive Compensation Plan.

Read SEC document
March 26, 2025 Filed Feb 18, 2026 01:30 UTC
Aminov ErezDirector · CEO and Chairman
GrantCommon Stock 62,500 $1.45 $90,625.00
Disclosure

SEC source: 0001493152-26-007226 · ownership.xml · nonDerivative · entry 2

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,592,666

F1 · kind: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4.

F2 · kind: Represents grants of RSUs with underlying shares of Common Stock under the Issuer's 2024 Omnibus Equity Incentive Plan (the "Plan"), for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The RSUs hereunder vested upon issuance.

Read SEC document
March 26, 2025 Filed Feb 18, 2026 01:30 UTC
Aminov ErezDirector · CEO and Chairman
GrantCommon Stock 62,500 $1.45 $90,625.00
Disclosure

SEC source: 0001493152-26-007226 · ownership.xml · nonDerivative · entry 1

Aminov Erez · CIK 0001986112 · Director · CEO and Chairman

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,530,166

F1 · kind: Represents the grant of Issuer's common stock, par value $0.0001 ("Common Stock") that should have been reported on Form 4.

F2 · kind: Represents grants of RSUs with underlying shares of Common Stock under the Issuer's 2024 Omnibus Equity Incentive Plan (the "Plan"), for awards granted in accordance with the Issuer's CEO's Long-Term Incentive Plan. The RSUs hereunder vested upon issuance.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 22:15 UTC GrantStock Options (right to buy) · Derivative 25,000 $0.00 Strike: $1.19 $0.00
Disclosure

SEC source: 0001493152-24-049507 · ownership.xml · derivative · entry 1

Whalen Matthew Pratt · CIK 0002033867 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-12-09

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.

F3 · balance_after: 25,000 stock options were issued to the Reporting Person on the Grant Date, pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated. 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 22:15 UTC GrantStock Options (right to buy) · Derivative 50,000 $0.00 Strike: $1.19 $0.00
Disclosure

SEC source: 0001493152-24-049506 · ownership.xml · derivative · entry 1

Shekhat Denil Nanji · CIK 0002016605 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-12-09

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.

F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on December 6, 2024, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $1.19 each.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 22:15 UTC GrantStock Options (right to buy) · Derivative 25,000 $0.00 Strike: $1.19 $0.00
Disclosure

SEC source: 0001493152-24-049504 · ownership.xml · derivative · entry 1

Del Giudice Matthew Paul · CIK 0002016630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 25,000 shares

Expires 2034-12-09

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.

F3 · balance_after: Represents 25,000 stock options that were issued to the Reporting Person on December 6, 2024, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $1.19 each.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 22:15 UTC GrantStock Options (right to buy) · Derivative 25,000 $0.00 Strike: $1.19 $0.00
Disclosure

SEC source: 0001493152-24-049505 · ownership.xml · derivative · entry 1

MacPherson Edward Clouston · CIK 0002015989 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-12-09

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.

F3 · balance_after: Represents 25,000 stock options that were issued to the Reporting Person on December 6, 2024, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $1.19 each.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 22:15 UTC
Yanez MichelleChief Financial Officer
GrantStock Options (right to buy) · Derivative 150,000 $0.00 Strike: $1.19 $0.00
Disclosure

SEC source: 0001493152-24-049508 · ownership.xml · derivative · entry 1

Yanez Michelle · CIK 0001958023 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2034-12-09

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.

F3 · balance_after: Represents 150,000 stock options that were issued to the Reporting Person on December 6, 2024, that vest in equal halves on the six- and 12-month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $1.19 each.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 22:15 UTC
Aminov ErezDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 500,000 $0.00 $0.00
Disclosure

SEC source: 0001493152-24-049503 · ownership.xml · derivative · entry 2

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2034-12-09

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F5 · derivative.exercise_date: The RSUs were issued to the Reporting Person on the Grant Date, pursuant to the Plan. Half of the shares subject to the RSU shall vest on the Grant Date and the remaining half of the shares subject to the RSU shall vest six months after the Grant Date.

F6 · balance_after: Represents 500,000 RSUs that were issued to the Reporting Person on December 6, 2024 under the Plan. Half of the shares subject to the RSU shall vest on the Grant Date and the remaining half of the shares subject to the RSU shall vest six months after the Grant Date.

Read SEC document
December 09, 2024 Filed Dec 10, 2024 22:15 UTC
Aminov ErezDirector · Chief Executive Officer
GrantStock Options (right to buy) · Derivative 2,000,000 $0.00 Strike: $1.19 $0.00
Disclosure

SEC source: 0001493152-24-049503 · ownership.xml · derivative · entry 1

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,000,000

Underlying: Common Stock · 2,000,000 shares

Expires 2034-12-09

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on December 6, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on December 6, 2024 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). Half of the shares subject to the option shall vest on the Grant Date and the remaining half of the shares subject to the option shall vest six months after the Grant Date.

F3 · balance_after: Represents 2,000,000 stock options that were issued to the Reporting Person on December 6, 2024 under the Plan. Half of the shares subject to the option shall vest on the Grant Date and the remaining half of the shares subject to the option shall vest six months after the Grant Date.

Read SEC document
November 20, 2024 Filed Nov 27, 2024 21:15 UTC
Aminov ErezDirector · Chief Executive Officer
SaleCommon Stock 44,590 $1.27 $56,629.30
Disclosure

SEC source: 0001493152-24-047998 · ownership.xml · nonDerivative · entry 2

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,061,200

F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the Reporting Person on 8/20/2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions.

Read SEC document
November 19, 2024 Filed Nov 27, 2024 21:15 UTC
Aminov ErezDirector · Chief Executive Officer
SaleCommon Stock 55,410 $1.39 $77,019.90
Disclosure

SEC source: 0001493152-24-047998 · ownership.xml · nonDerivative · entry 1

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,105,790

F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the Reporting Person on 8/20/2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions.

Read SEC document
August 28, 2024 Filed Aug 30, 2024 20:05 UTC SaleCommon Stock 200,000 $1.96 $392,000.00
Disclosure

SEC source: 0001493152-24-034584 · ownership.xml · nonDerivative · entry 1

McNulty Brian Patrick · CIK 0001996353 · 10% owner

Bay Shore Trust · CIK 0001986593 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 2,540,270

F1 · ownership.nature: As trustee of the Bay Shore Trust and the Celeste J Williams Lifetime QTIP Trust, Mr. McNulty has sole voting and dispositive power over the shares held by each trust, and, as a result is deemed to have beneficial ownership (as determined under Section 13(d) of the Exchange Act) of the securities held by the trusts. The address for the Bay Shore Trust is 900 West Platt Street, Suite 200, Tampa, Florida, 33606.

Read SEC document
June 18, 2024 Filed Jun 21, 2024 20:30 UTC GrantNonqualified Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $0.71 $0.00
Disclosure

SEC source: 0001493152-24-024753 · ownership.xml · derivative · entry 1

Shekhat Denil Nanji · CIK 0002016605 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,666

Underlying: Common Stock · 50,000 shares

Expires 2034-06-18

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the Nasdaq Official Closing Price of the Issuer's common stock on June 18, 2024, the date of the grant.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on June 18, 2024, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"), and in accordance with the terms of a consulting agreement dated June 18, 2024, by and between the Reporting Person and MIRA Pharmaceuticals, Inc. The stock options will vest in three equal tranches, with the first tranche vesting immediately on the grant date of June 18, 2024, the second tranche vesting on December 18, 2024, and the final tranche vesting on June 18, 2025.

F3 · balance_after: Represents (i) 25,000 stock options that were issued to the Reporting person on March 25, 2024, that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $1.16 each and (ii) 16,666 stock options that were issued to the Reporting Person on June 18, 2024, that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.71 each.

Read SEC document
May 28, 2024 Filed May 30, 2024 22:00 UTC
Aminov ErezDirector · Chief Executive Officer
GrantIncentive Stock Options (right to buy) · Derivative 379,000 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001493152-24-022029 · ownership.xml · derivative · entry 1

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 629,000

Underlying: Common Stock · 379,000 shares

Expires 2034-05-28

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on May 28, 2024.

F2 · derivative.exercise_date: The stock options were issued to the Reporting Person on May 28, 2024, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). The stock options vested in full and became exercisable immediately upon issuance on the grant date, May 28, 2024.

F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on April 28, 2023 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $5.00 each, (ii) 150,000 stock options that were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17, 2023 at an exercise price of $6.50 each, (iii) 50,000 stock options that were issued to the Reporting Person on August 17, 2023 that vested in full and became exercisable on April 28, 2024, pursuant to a grant under the Issuer's Plan at an exercise price of $6.50 each, and (iv) 379,000 stock options that were issued to the Reporting Person on May 28, 2024 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $0.84 each.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:42 UTC
Aminov ErezDirector · Chief Executive Officer
PurchaseCommon Stock 800 $0.97 $776.00
Disclosure

SEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 8

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 382,200

F1 · ownership.direct: These securities are directly owned by Mr. Aminov.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:42 UTC
Aminov ErezDirector · Chief Executive Officer
PurchaseCommon Stock 800 $1.01 $808.00
Disclosure

SEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 7

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 381,400

F1 · ownership.direct: These securities are directly owned by Mr. Aminov.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:42 UTC
Aminov ErezDirector · Chief Executive Officer
PurchaseCommon Stock 600 $0.87 $522.00
Disclosure

SEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 6

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,600

F1 · ownership.direct: These securities are directly owned by Mr. Aminov.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:42 UTC
Aminov ErezDirector · Chief Executive Officer
PurchaseCommon Stock 1,000 $0.85 $850.00
Disclosure

SEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 5

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,000

F1 · ownership.direct: These securities are directly owned by Mr. Aminov.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:42 UTC
Aminov ErezDirector · Chief Executive Officer
PurchaseCommon Stock 2,000 $0.84 $1,680.00
Disclosure

SEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 4

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 379,000

F1 · ownership.direct: These securities are directly owned by Mr. Aminov.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:42 UTC
Aminov ErezDirector · Chief Executive Officer
PurchaseCommon Stock 500 $1.02 $510.00
Disclosure

SEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 3

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 377,000

F1 · ownership.direct: These securities are directly owned by Mr. Aminov.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:42 UTC
Aminov ErezDirector · Chief Executive Officer
PurchaseCommon Stock 1,000 $1.03 $1,030.00
Disclosure

SEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 2

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 376,500

F1 · ownership.direct: These securities are directly owned by Mr. Aminov.

Read SEC document
May 21, 2024 Filed May 22, 2024 21:42 UTC
Aminov ErezDirector · Chief Executive Officer
PurchaseCommon Stock 2,000 $1.00 $2,000.00
Disclosure

SEC source: 0001493152-24-021069 · ownership.xml · nonDerivative · entry 1

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375,500

F1 · ownership.direct: These securities are directly owned by Mr. Aminov.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 21:53 UTC
Aminov ErezDirector · Chief Executive Officer
GrantIncentive Stock Option (right to buy) · Derivative 300,000 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001493152-24-011573 · ownership.xml · derivative · entry 1

Aminov Erez · CIK 0001986112 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 300,000 shares

Expires 2034-03-26

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on March 26, 2024.

F2 · derivative.exercise_date: The options were granted under the Issuer's 2022 Amended and Restated Omnibus Incentive Plan (the "Plan") whereby 50% of such incentive options, or 150,000 options, will vest on the six month anniversary of the of the grant, or September 26, 2024, and the remaining 50% will vest on the first anniversary of the grant date, March 26, 2025.

F3 · balance_after: Represents 50,000 stock options that were issued to the Reporting Person on April 28, 2023 that were vested in full and became exercisable on the same date, pursuant to a grant under the Issuer's Plan at an exercise price of $5.00 each, (ii) 150,000 stock options were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17,2023 at an exercise price of $6.50 each and (iii) 50,000 stock options were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which will vest in full on April 28. 2024 at an exercise price of $6.50 each.

Read SEC document
March 26, 2024 Filed Mar 27, 2024 21:53 UTC
Yanez MichelleChief Financial Officer
GrantIncentive Stock Option (right to buy) · Derivative 150,000 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001493152-24-011574 · ownership.xml · derivative · entry 1

Yanez Michelle · CIK 0001958023 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,799

Underlying: Common Stock · 150,000 shares

Expires 2034-03-26

F1 · derivative.exercise_price: The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on March 26, 2024.

F2 · derivative.exercise_date: The options were granted under the Issuer's 2022 Amended and Restated Omnibus Incentive Plan (the "Plan") whereby 50% of such incentive options, or 75,000 options, will vest on the six month anniversary of the of the grant, or September 26, 2024, and the remaining 50% will vest on the first anniversary of the grant date, March 26, 2025.

F3 · balance_after: Represents (i) 3,334 stock options that were issued to the Reporting Person under the Plan that became exercisable on June 15, 2022 at an exercise price of $5.00 (ii) 3,333 stock options that were issued to the Reporting Person under the Plan that became exercise on June 15, 2023 at an exercise price of $5.00 each, (iii) 15,566 stock options were issued to the Reporting Person on April 28, 2023, pursuant to a grant under the Issuer's Plan which vested in full on April 28, 2024 at an exercise price of $6.50 each, (iv) 15,566 stock options were issued to the Reporting Person on April 28, 2023, pursuant to a grant under the Issuer's Plan which will vest in full on April 28, 2024 at an exercise price of $6.50 each (v) 20,000 stock options were issued to the Reporting Person on August 17, 2023, pursuant to a grant under the Issuer's Plan which vested in full on August 17, 2023 at an exercise price of $6.50 each.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:53 UTC GrantNonqualified Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $1.16 $0.00
Disclosure

SEC source: 0001493152-24-011572 · ownership.xml · derivative · entry 1

Shekhat Denil Nanji · CIK 0002016605 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 50,000 shares

Expires 2034-03-25

F1 · derivative.exercise_date: The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:53 UTC GrantNonqualified Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $1.16 $0.00
Disclosure

SEC source: 0001493152-24-011570 · ownership.xml · derivative · entry 1

Del Giudice Matthew Paul · CIK 0002016630 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 50,000 shares

Expires 2034-03-25

F1 · derivative.exercise_date: The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:53 UTC GrantNonqualified Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $1.16 $0.00
Disclosure

SEC source: 0001493152-24-011569 · ownership.xml · derivative · entry 1

MacPherson Edward Clouston · CIK 0002015989 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 50,000 shares

Expires 2034-03-25

F1 · derivative.exercise_date: The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025.

Read SEC document
March 25, 2024 Filed Mar 27, 2024 21:53 UTC GrantNonqualified Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $1.16 $0.00
Disclosure

SEC source: 0001493152-24-011571 · ownership.xml · derivative · entry 1

Jerman Michael Allen · CIK 0001979732 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 50,000 shares

Expires 2034-03-25

F1 · derivative.exercise_date: The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025.

Read SEC document
December 11, 2023 Filed Dec 27, 2023 22:33 UTC SaleCommon Stock 23,002 $1.55 $35,747.41
Disclosure

SEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 22

McNulty Brian Patrick · CIK 0001996353 · 10% owner

Bay Shore Trust · CIK 0001986593 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 660,000

F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.

Read SEC document
December 11, 2023 Filed Dec 27, 2023 22:33 UTC SaleCommon Stock 23,003 $1.55 $35,748.96
Disclosure

SEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 11

McNulty Brian Patrick · CIK 0001996353 · 10% owner

Bay Shore Trust · CIK 0001986593 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 2,740,270

F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.

Read SEC document
December 08, 2023 Filed Dec 27, 2023 22:33 UTC SaleCommon Stock 9,527 $1.61 $15,317.51
Disclosure

SEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 21

McNulty Brian Patrick · CIK 0001996353 · 10% owner

Bay Shore Trust · CIK 0001986593 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 683,002

F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.

Read SEC document
December 08, 2023 Filed Dec 27, 2023 22:33 UTC SaleCommon Stock 9,526 $1.61 $15,315.90
Disclosure

SEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 10

McNulty Brian Patrick · CIK 0001996353 · 10% owner

Bay Shore Trust · CIK 0001986593 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 2,763,273

F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.

Read SEC document
December 07, 2023 Filed Dec 27, 2023 22:33 UTC SaleCommon Stock 16,667 $1.89 $31,578.96
Disclosure

SEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 20

McNulty Brian Patrick · CIK 0001996353 · 10% owner

Bay Shore Trust · CIK 0001986593 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 692,529

F2 · ownership.nature: These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.

Read SEC document
December 07, 2023 Filed Dec 27, 2023 22:33 UTC SaleCommon Stock 16,666 $1.89 $31,577.07
Disclosure

SEC source: 0000897069-23-001850 · form4.xml · nonDerivative · entry 9

McNulty Brian Patrick · CIK 0001996353 · 10% owner

Bay Shore Trust · CIK 0001986593 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 2,772,799

F1 · ownership.nature: These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.